Innovation Pharmaceuticals Inc (IPIX)

[thefamilyman]

Is the FDA application waiting on that pre-print to come out? It’s time for the RBL to put together that pre-print based on what they have already accomplished. Hopefully they are in the process of writing it up while testing continues. If for some reason they can’t write and test, then maybe it’s time for the writing to take priority. In this case, Remdesivir adds no significant benefit and lowers the safety profile. I hope the pre-print was not delayed for the Remdesivir testing.

From the PR,

In other newly conducted lab testing at the RBL, Brilacidin was shown to inhibit SARS-CoV-2 in a human intestinal epithelial cell line and in primary fibroblast cells obtained from human donors. The Company has been informed by the RBL that it is nearing completion of its in vitro testing of Brilacidin against SARS-CoV-2 and will be submitting findings for peer-review publication. The publication will be solely focused on Brilacidin, with a pre-print made available.